Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 4/2016

01.04.2016 | Original Article

IV Acetaminophen Results in Lower Hospital Costs and Emergency Room Visits Following Bariatric Surgery: a Double-Blind, Prospective, Randomized Trial in a Single Accredited Bariatric Center

verfasst von: Maher El Chaar, Jill Stoltzfus, Leonardo Claros, Tara Wasylik

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Postoperative pain control in bariatric surgery is challenging, despite use of intravenous (IV) narcotics. IV acetaminophen is one pain control alternative.

Objective

The aim of this study was to investigate the economic impact of IV acetaminophen in bariatric surgery and its effect on patients’ pain, satisfaction, and hospital length of stay.

Methods

In a randomized controlled trial, Group 1 (treatment) received IV acetaminophen plus IV narcotics 30 min before surgery, then medication plus IV narcotics/PO narcotics for the remaining 18 h. Group 2 (control) received IV normal saline plus IV/PO narcotics. Patients underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (SG). Primary outcomes included direct hospital costs, length of stay, postoperative pain, and patient satisfaction. Secondary outcomes included indirect costs, rescue narcotics dosage, and 30-day outcomes.

Results

Mean direct hospital cost in the treatment group (n = 50) was $3089.18 versus $2991.62 for the control group (n = 50) (p > 0.05). Pain scores did not differ significantly (p = 0.61). After adjusting for surgery type, there was no significant difference in length of stay (p = 0.95). Significantly more control group patients incurred surgery-related indirect costs (10 versus 2 %, p < 0.05), with greater presentation to the emergency department (ED) for abdominal pain (5/50 versus 1/50), yielding higher total indirect costs ($39,293 versus $13,185).

Conclusions

Using IV acetaminophen for postoperative pain management produced notable indirect cost savings and reduced ED visits in the first 30 days postoperatively, with good safety and tolerance. Decreased statistical power may have accounted for certain non-significant findings.
Literatur
1.
2.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–37.CrossRefPubMed
3.
Zurück zum Zitat Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577–85.CrossRefPubMed Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577–85.CrossRefPubMed
4.
Zurück zum Zitat Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567–76.CrossRefPubMedPubMedCentral Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567–76.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat DeMaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS Bariatric Surgery Center of Excellence program as reported in the Bariatric Outcomes Longitudinal Database. Transactions of the Meeting of the American Surgical Association 2010;128:166–75.CrossRef DeMaria EJ, Winegar DA, Pate VW, Hutcher NE, Ponce J, Pories WJ. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS Bariatric Surgery Center of Excellence program as reported in the Bariatric Outcomes Longitudinal Database. Transactions of the Meeting of the American Surgical Association 2010;128:166–75.CrossRef
6.
Zurück zum Zitat Gould JC, Kent KC, Wan Y, Rajamanickam V, Leverson G, Campos GM. Perioperative safety and volume: outcomes relationships in bariatric surgery: a study of 32,000 patients. J Am Coll Surg 2011;213:771–7.CrossRefPubMed Gould JC, Kent KC, Wan Y, Rajamanickam V, Leverson G, Campos GM. Perioperative safety and volume: outcomes relationships in bariatric surgery: a study of 32,000 patients. J Am Coll Surg 2011;213:771–7.CrossRefPubMed
7.
Zurück zum Zitat Jafari MD, Jafari F, Young MT, Smith BR, Phalen MJ, Nguyen NT. Volume and outcome relationship in bariatric surgery in the laparoscopic era. Surg Endosc 2013;27:4539–46.CrossRefPubMed Jafari MD, Jafari F, Young MT, Smith BR, Phalen MJ, Nguyen NT. Volume and outcome relationship in bariatric surgery in the laparoscopic era. Surg Endosc 2013;27:4539–46.CrossRefPubMed
8.
Zurück zum Zitat Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, Merkow RP, et al. First report from the American College of Surgeons Bariatric Surgery Center Network. Annals of Surgery 2011;254:410–22.CrossRefPubMedPubMedCentral Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, Merkow RP, et al. First report from the American College of Surgeons Bariatric Surgery Center Network. Annals of Surgery 2011;254:410–22.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2014;6:347–55.CrossRef DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2014;6:347–55.CrossRef
10.
Zurück zum Zitat Chaar El M, Claros L, Ezeji GC, Miletics M, Stoltzfus J. Improving outcome of bariatric surgery: best practices in an accredited surgical center. Obes Surg 2014;24:1057–63.PubMed Chaar El M, Claros L, Ezeji GC, Miletics M, Stoltzfus J. Improving outcome of bariatric surgery: best practices in an accredited surgical center. Obes Surg 2014;24:1057–63.PubMed
11.
Zurück zum Zitat Wininger SJ, Miller H, Minkowitz HS, Royal MA, Ang RY, Breitmeyer JB, et al. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clinical Therapeutics 2010;32:2348–69.CrossRefPubMed Wininger SJ, Miller H, Minkowitz HS, Royal MA, Ang RY, Breitmeyer JB, et al. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clinical Therapeutics 2010;32:2348–69.CrossRefPubMed
12.
Zurück zum Zitat Frank Peacock W, Breitmeyer JB, Pan C, Smith WB, Royal MA. A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever. Acad Emerg Med 2011;18:360–6.CrossRefPubMed Frank Peacock W, Breitmeyer JB, Pan C, Smith WB, Royal MA. A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever. Acad Emerg Med 2011;18:360–6.CrossRefPubMed
13.
Zurück zum Zitat Juhl GI, Norholt SE, Tonnesen E, Hiesse-Provost O, Jensen TS. Analgesic efficacy and safety of intravenous paracetamol (acetaminophen) administered as a 2 g starting dose following third molar surgery. European Journal of Pain 2012;10:371–1.CrossRef Juhl GI, Norholt SE, Tonnesen E, Hiesse-Provost O, Jensen TS. Analgesic efficacy and safety of intravenous paracetamol (acetaminophen) administered as a 2 g starting dose following third molar surgery. European Journal of Pain 2012;10:371–1.CrossRef
14.
Zurück zum Zitat Moller PL, Juhl GI, Payen-Champenois C, Skoglund LA. Intravenous acetaminophen (paracetamol): comparable analgesic efficacy, but better local Safety than its prodrug, propacetamol, for postoperative pain after third molar surgery. Anesthesia & Analgesia 2005;101:90–6.CrossRef Moller PL, Juhl GI, Payen-Champenois C, Skoglund LA. Intravenous acetaminophen (paracetamol): comparable analgesic efficacy, but better local Safety than its prodrug, propacetamol, for postoperative pain after third molar surgery. Anesthesia & Analgesia 2005;101:90–6.CrossRef
15.
Zurück zum Zitat Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: A systematic review and meta-analysis. Surgery 2007;142:621–35.CrossRefPubMed Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: A systematic review and meta-analysis. Surgery 2007;142:621–35.CrossRefPubMed
16.
Zurück zum Zitat Carlsson LMS, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in swedish obese subjects. N Engl J Med 2012;367:695–704.CrossRefPubMed Carlsson LMS, Peltonen M, Ahlin S, Anveden Å, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in swedish obese subjects. N Engl J Med 2012;367:695–704.CrossRefPubMed
17.
Zurück zum Zitat Salem L, Devlin A, Sullivan SD, Flum DR. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis 2008;4:26–32.CrossRefPubMedPubMedCentral Salem L, Devlin A, Sullivan SD, Flum DR. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis 2008;4:26–32.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord 2003;27:1167–77.CrossRefPubMed Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord 2003;27:1167–77.CrossRefPubMed
19.
Zurück zum Zitat Weiner JP, Goodwin SM, Chang H-Y, Bolen SD, Richards TM, Johns RA, et al. Impact of bariatric surgery on health care costs of obese persons. JAMA Surg 2013;148:555.CrossRefPubMed Weiner JP, Goodwin SM, Chang H-Y, Bolen SD, Richards TM, Johns RA, et al. Impact of bariatric surgery on health care costs of obese persons. JAMA Surg 2013;148:555.CrossRefPubMed
20.
Zurück zum Zitat Gouvas N, Tan E, Windsor A, Xynos E, Tekkis PP. Fast-track versus standard care in colorectal surgery: a meta-analysis update. Int J Colorectal Dis 2009;24:1119–31.CrossRefPubMed Gouvas N, Tan E, Windsor A, Xynos E, Tekkis PP. Fast-track versus standard care in colorectal surgery: a meta-analysis update. Int J Colorectal Dis 2009;24:1119–31.CrossRefPubMed
21.
Zurück zum Zitat Carli F, Charlebois P, Baldini G, Cachero O, Stein B. Une approche pluridisciplinaire intégrée visant la mise en œuvre d’un programme accéléré pour la chirurgie colorectale par laparoscopie. Can J Anesth/J Can Anesth 2009;56:837–42.CrossRef Carli F, Charlebois P, Baldini G, Cachero O, Stein B. Une approche pluridisciplinaire intégrée visant la mise en œuvre d’un programme accéléré pour la chirurgie colorectale par laparoscopie. Can J Anesth/J Can Anesth 2009;56:837–42.CrossRef
22.
Zurück zum Zitat Counihan T, Favuzza J. Fast track colorectal surgery. Clinics in Colon and Rectal Surgery 2009;22:060–72.CrossRef Counihan T, Favuzza J. Fast track colorectal surgery. Clinics in Colon and Rectal Surgery 2009;22:060–72.CrossRef
23.
Zurück zum Zitat Burns EM, Naseem H, Bottle A, Lazzarino AI, Aylin P, Darzi A, et al. Introduction of laparoscopic bariatric surgery in England: observational population cohort study. BMJ 2010;341:c4296–6.CrossRefPubMed Burns EM, Naseem H, Bottle A, Lazzarino AI, Aylin P, Darzi A, et al. Introduction of laparoscopic bariatric surgery in England: observational population cohort study. BMJ 2010;341:c4296–6.CrossRefPubMed
24.
Zurück zum Zitat Kellogg TA, Swan T, Leslie DA, Buchwald H, Ikramuddin S. Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2009;5:416–24.CrossRefPubMed Kellogg TA, Swan T, Leslie DA, Buchwald H, Ikramuddin S. Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2009;5:416–24.CrossRefPubMed
25.
Zurück zum Zitat Nguyen NT, Slone JA, Nguyen X-MT, Hartman JS, Hoyt DB. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity. transactions of the Meeting of the American Surgical Association 2009;127:262–72.CrossRef Nguyen NT, Slone JA, Nguyen X-MT, Hartman JS, Hoyt DB. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity. transactions of the Meeting of the American Surgical Association 2009;127:262–72.CrossRef
26.
Zurück zum Zitat Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361:445–54.CrossRefPubMed Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009;361:445–54.CrossRefPubMed
Metadaten
Titel
IV Acetaminophen Results in Lower Hospital Costs and Emergency Room Visits Following Bariatric Surgery: a Double-Blind, Prospective, Randomized Trial in a Single Accredited Bariatric Center
verfasst von
Maher El Chaar
Jill Stoltzfus
Leonardo Claros
Tara Wasylik
Publikationsdatum
01.04.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 4/2016
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3088-0

Weitere Artikel der Ausgabe 4/2016

Journal of Gastrointestinal Surgery 4/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.